MoneyWorks4Me

Valiant Laboratories - Quaterly Results

08 Aug 2025 Evaluate
The total revenue hovered 170.11% to Rs. 510.07 millions for the June 2025 quarter as against Rs. 188.84 millions during the corresponding quarter last year.The Total Profit for the quarter ended June 2025 of Rs. 18.17 millions grew from Rs.-10.05 millions Operating profit Margin for the quarter ended June 2025 improved to 30.34% as compared to -2.14% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 510.07 188.84 170.11 510.07 188.84 170.11 1333.62 1820.52 -26.75
Other Income 6.71 21.74 -69.14 6.71 21.74 -69.14 54.28 96.82 -43.94
PBIDT 30.34 -2.14 -1517.76 30.34 -2.14 -1517.76 7.53 12.73 -40.85
Interest 0.73 0.53 37.74 0.73 0.53 37.74 1.75 0.78 124.36
PBDT 29.61 -2.67 -1208.99 29.61 -2.67 -1208.99 5.78 11.95 -51.63
Depreciation 5.14 5.04 1.98 5.14 5.04 1.98 20.25 19.48 3.95
PBT 24.47 -7.71 -417.38 24.47 -7.71 -417.38 -14.47 -7.53 92.16
TAX 6.30 2.34 169.23 6.30 2.34 169.23 7.02 -10.93 -164.23
Deferred Tax 0.46 1.46 -68.49 0.46 1.46 -68.49 6.46 -1.11 -681.98
PAT 18.17 -10.05 -280.80 18.17 -10.05 -280.80 -21.49 3.40 -732.06
Equity 434.50 434.50 0.00 434.50 434.50 0.00 434.50 434.50 0.00
PBIDTM(%) 5.95 -1.13 -624.90 5.95 -1.13 -624.90 0.56 0.70 -19.26
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..